Novel Use of Multivariate Joint Modelling to Identify Patient Level Factors Associated With Treatment Failure – Example of Botox Treatment for Patients With Overactive Bladder

Value in Health - United Kingdom
doi 10.1016/j.jval.2013.08.1761
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Mp65-16 Predictor Factors for Successful Treatment of Solifenacin in Patients With Overactive Bladder

Journal of Urology
Urology
2016English

Factors Associated With Improvements in Patient-Reported Outcomes During Mirabegron or Antimuscarinic Treatment of Overactive Bladder Syndrome: A Registry Study (PERSPECTIVE)

Advances in Therapy
MedicinePharmacology
2019English

Correction To: Imidafenacin for the Treatment of Overactive Bladder

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2013English

Factors Associated With Beliefs About Adherence to Non-Pharmacological Treatment of Patients With Heart Failure

Revista da Escola de Enfermagem da U S P
Nursing
2014English

Practical Aspects of Botulinum Toxin-A Treatment in Patients With Overactive Bladder Syndrome

International Neurourology Journal
NeurologyUrology
2015English

OnabotulinumtoxinA for the Treatment of Overactive Bladder

Research and Reports in Urology
Urology
2014English

AE9C90CB: A Novel, Bladder-Selective Muscarinic Receptor Antagonist for the Treatment of Overactive Bladder

British Journal of Pharmacology
Pharmacology
2010English

Stepwise Treatment for Overactive Bladder Is Prudent

Canadian Urological Association Journal
Urology
2017English

Factors Influencing Return for Maintenance Treatment With Percutaneous Tibial Nerve Stimulation for the Management of the Overactive Bladder

BJU International
Urology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy